Semaglutide is significantly cheaper in countries like France and Germany compared to the U.S., with the cost being 143% and 572% lower, respectively
Hair loss is reported across the GLP-1 class (around 3% on injectable Wegovy, 5 to 6% on injectable Mounjaro) and is usually a temporary response to rapid weight loss rather than a direct effect of the drug
Overtime, the appetite-curbing benefits from boosting GLP-1 levels have made these types of medications increasingly popular with people who are non-diabetic but want to shed extra pounds
Your genetic predispositions in FTO (appetite regulation) and MC4R (energy homeostasis) variants may help explain individual metabolic response patterns
Although not usually needed, we can even suggest pharmacogenomic testing to determine how they metabolize medication
Absorption is lower than injection, but the peptide reaches target dermal tissue directly and there's no needle